STRENGTHENING HUMAN IMMUNITY USING ROBUST ANTIBODY THERAPIES

SparX Biopharmaceutical Corp. is a research-based development-stage biopharmaceutical company, dedicated to the mission of “strengthening human immunity using robust antibody therapies” through the discovery and development of innovative immuno-oncology agents.
about us

SparX Biopharmaceutical Corp.

Cure Cancer by Targeting Multiple Pathways with the Right Therapeutic Strategy

Target discovery and validation has historically been the bottleneck in drug development.
learn more

SparX Pipeline

Stimulate the Untapped Potential of the Innate and Adaptive Immunity

Learn More

SparX Techologies

SAILINGTM

An integrated approach to discovering and building antibodies​

Learn More

SYNMABTM

Design, Selection, Optimization of multi-specific antibodies​

Learn More

SPARX BIFUNCTIONAL ADC PLATFORM

Universally empowering ADCs with high specificity, sensitivity and activity​

Learn More
More Technologies

SparX Capabilities

SparX is an integrated company with discovery and development platforms as well as expertise and facilities to support cGMP biologics production and release. This includes cell line development, upstream and downstream process development and optimization, and drug substance production and release.
Learn More

News

Chicago, USA January 17, 2022

December 7, 2022

With a mission of “Bolstering human immunity by utilizing empowered antibody therapies”, the SparX Group announced that the FDA has approved their IND application for

Read More »
All News

Get in Touch with SparX

  • 700 E. Business Center Dr. Mount Prospect, IL 60056
  • +1 847 257 7910 (Direct)
  • +1 224 580 2979 (extension)
  • info@sparxbio.com
Contact Us
small_c_popup.png

Learn how we helped 100 top brands gain success.

Let's have a chat